Liposic

Carbomer, the active ingredient in Liposic, is a pharmaceutical excipient presented as a gel-forming agent for ocular use. It functions as a viscosity enhancer in eye preparations, improving drug residence time on the ocular surface. GNH USA supplies Liposic as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Liposic, containing carbomer, is used as a viscosity enhancer in ophthalmic formulations.

Dry eye syndrome: improves tear film stability and prolongs ocular surface lubrication. Post‑operative ocular inflammation: provides sustained delivery of anti‑inflammatory agents. Allergic conjunctivitis: enhances residence time of antihistamine eye drops. Keratitis: supports prolonged contact of antimicrobial eye drops. Glaucoma therapy: aids in controlled release of intra‑ocular pressure‑lowering agents.

Carbomer‑based ophthalmic gels are generally well tolerated, but ocular irritation can occur.

Common Side Effects: - Transient blurred vision: temporary reduction in visual acuity after instillation. - Ocular irritation: mild burning or stinging sensation. - Foreign body sensation: feeling of something in the eye. - Mild conjunctival redness: slight redness without discharge. - Excessive tearing: increased lacrimation. - Temporary visual haze: brief cloudiness of vision.

Serious or Rare Side Effects: - Allergic contact dermatitis: localized swelling, itching, or rash. - Corneal ulceration: rare development of corneal lesions. - Severe eye pain: intense discomfort requiring medical evaluation. - Vision loss: extremely rare, sudden loss of sight. - Persistent inflammation: ongoing ocular inflammation beyond expected duration. - Endophthalmitis: rare intra‑ocular infection.

When using Liposic, consider the following safety measures.

Patient counseling: advise that the product is an excipient and may cause temporary visual changes. Allergy screening: avoid use in patients with known carbomer hypersensitivity. Monitor irritation: observe for signs of ocular discomfort or redness. Compatibility testing: do not combine with other ophthalmic gels without confirming stability. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Carbomer may interact with other ophthalmic products, affecting formulation stability.

Major Interactions (Avoid): - Co‑administration with other gel‑forming agents: may result in excessive viscosity. - Incompatible preservatives: certain preservatives can destabilize the carbomer gel matrix. - High‑ionic strength solutions: can cause gel breakdown.

Moderate Interactions (Monitor Closely): - Contact lens wear: may reduce drug absorption from the gel. - Concurrent ocular antibiotics: may alter release profile of the active drug.